Wuhan Keqian Biology Co.,Ltd (688526.SS)
CNY 14.62
(-0.27%)
CNY 14.62
(-0.27%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 307.99 Million CNY | 87.41% |
| 2022 | 310.98 Million CNY | 10.86% |
| 2021 | 280.51 Million CNY | 40.25% |
| 2020 | 200.01 Million CNY | 34.88% |
| 2019 | 148.29 Million CNY | -22.88% |
| 2018 | 192.27 Million CNY | 14.98% |
| 2017 | 167.22 Million CNY | 68.28% |
| 2016 | 99.37 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 71.64 Million CNY | -24.24% |
| 2024 Q1 | 52.26 Million CNY | -90.88% |
| 2024 Q2 | 64.39 Million CNY | 23.21% |
| 2023 Q4 | 573.03 Million CNY | 646.54% |
| 2023 FY | 582.8 Million CNY | 87.41% |
| 2023 Q3 | 76.75 Million CNY | 6.67% |
| 2023 Q2 | 71.95 Million CNY | -4.07% |
| 2023 Q1 | 75 Million CNY | -23.25% |
| 2022 FY | 310.98 Million CNY | 10.86% |
| 2022 Q3 | 81.16 Million CNY | 8.63% |
| 2022 Q2 | 74.72 Million CNY | 30.25% |
| 2022 Q1 | 57.36 Million CNY | -17.03% |
| 2022 Q4 | 97.72 Million CNY | 20.4% |
| 2021 Q2 | 60.54 Million CNY | -25.63% |
| 2021 Q1 | 81.41 Million CNY | 43.27% |
| 2021 FY | 280.51 Million CNY | 40.25% |
| 2021 Q4 | 69.14 Million CNY | -0.39% |
| 2021 Q3 | 69.41 Million CNY | 14.65% |
| 2020 FY | 200.01 Million CNY | 34.88% |
| 2020 Q4 | 56.82 Million CNY | -6.15% |
| 2020 Q1 | 35.44 Million CNY | -10.55% |
| 2020 Q2 | 47.19 Million CNY | 33.15% |
| 2020 Q3 | 60.54 Million CNY | 28.28% |
| 2019 Q2 | 34.6 Million CNY | -0.17% |
| 2019 Q1 | 34.66 Million CNY | 0.0% |
| 2019 Q4 | 39.62 Million CNY | 3.04% |
| 2019 Q3 | 38.46 Million CNY | 11.13% |
| 2019 FY | 148.29 Million CNY | -22.88% |
| 2018 FY | 192.27 Million CNY | 14.98% |
| 2017 FY | 167.22 Million CNY | 68.28% |
| 2016 FY | 99.37 Million CNY | 0.0% |